PROPOXYPHENE HYDROCHLORIDE 65 Drug Patent Profile
✉ Email this page to a colleague
When do Propoxyphene Hydrochloride 65 patents expire, and when can generic versions of Propoxyphene Hydrochloride 65 launch?
Propoxyphene Hydrochloride 65 is a drug marketed by Warner Chilcott and is included in one NDA.
The generic ingredient in PROPOXYPHENE HYDROCHLORIDE 65 is propoxyphene hydrochloride. There are twenty-seven drug master file entries for this compound. Additional details are available on the propoxyphene hydrochloride profile page.
Summary for PROPOXYPHENE HYDROCHLORIDE 65
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 8 |
Patent Applications: | 2,149 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROPOXYPHENE HYDROCHLORIDE 65 at DailyMed |
Recent Clinical Trials for PROPOXYPHENE HYDROCHLORIDE 65
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mansoura University | Phase 1/Phase 2 |
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
US Patents and Regulatory Information for PROPOXYPHENE HYDROCHLORIDE 65
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Warner Chilcott | PROPOXYPHENE HYDROCHLORIDE 65 | propoxyphene hydrochloride | CAPSULE;ORAL | 083786-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |